Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?

Hepatology

Volumn 36, Issue 2, 2002, Pages 403-409

  Chitturi, Shivakumar ^a   Farrell, Geoffrey ^a   Frost, Linda ^a   Kriketos, Adamandia ^b   Lin, Rita ^a   Liddle, Christopher ^a   Samarasinghe, Dev ^a   George, Jacob ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C PEPTIDE; GLUCOSE; INSULIN; LEPTIN; LIPID;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STEATOSIS;

EID: 0036329894     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.34738     Document Type: Article

References (49)

1. Leptin and the regulation of body weight in mammals
2. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia
3. Diseases of liporegulation: New perspective on obesity and related disorders
4. Rapid reversal of liver steatosis by leptin in oblob mice
5. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
6. NASH: From liver diseases to metabolic disorders and back to clinical hepatology
7. Nonalcoholic fatty liver disease: An agenda for clinical research
8. Nonalcoholic fatty liver disease
9. New drug targets for type 2 diabetes and the metabolic syndrome
10. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines
11. Nonalcoholic steatohepatitis (NASH): A disease of emerging identity and importance
12. Etiopathogenesis of nonalcoholic steatohepatitis
13. Leptin induces oxidative stress in human endothelial cells
14. Leptin is required for the development of hepatic fibrosis
15. Leptin regulates proinflammatory immune responses
16. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals
17. Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice
18. Association of nonalcoholic fatty liver disease with insulin resistance
19. Human leptin: From an adipocyte hormone to an endocrine mediator
20. Nonalcoholic steato-hepatitis: Impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis
21. Hepatocyte cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
22. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
23. Transection of the oesophagus for bleeding oesophageal varices
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
25. Guidelines for healthy weight
26. The Asia-Pacific perspective: Redefining obesity and its treatment
27. Clinical practice recommendations 2000
28. Gender-dependent alterations in serum leptin in alcoholic cirrhosis
29. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis
30. TNF-α is not the cause of fatty liver disease in obese diabetic mice
31. Modulation of insulin activities by leptin
32. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation
33. Increased leptin resistance as rats grow to maturity
34. The role of leptin resistance in the lipid abnormalities of aging
35. Postmortem findings in congenital generalized lipodystrophy
36. Leptin-replacement therapy for lipodystrophy
37. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets
38. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis
39. Hepatitis C and the leptin system: Bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy
40. Serum leptin levels in patients with nonalcoholic steatohepatitis
41. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
42. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
43. Non-alcoholic fatty liver: Another feature of the metabolic syndrome?
44. Elevated bound leptin correlates with energy expenditure in cirrhotics
45. Modulation of circulating leptin levels by its soluble receptor
46. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes
47. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: Comparison with PPAR-gamma activation
48. Metformin in nonalcoholic steatohepatitis